Medicare Is Contracting Directly With Technology Companies, and the Program Is Expanding

Oct 7, 2026

There is a CMS Innovation Center model that contracts technology organizations directly, pairs them with Medicare physicians, and pays for technology-supported chronic disease management. It is called the ACCESS Model, and in September 2026 CMS indicated that new clinical tracks will be added next spring, including heart failure and substance use disorders.

The current tracks address cardio-kidney-metabolic disease states, anxiety and depression, and musculoskeletal conditions. The model currently serves traditional Medicare enrollees, and CMS leadership has signaled interest in eventually extending the approach into Medicare Advantage and Medicaid.

For any company building chronic care technology, that sequence deserves careful reading. Most health technology go-to-market assumes the company sells to a provider or a payer, who then bills Medicare. This is a different shape entirely. The technology organization is a contracted participant in the model rather than a vendor standing two steps away from the payment.

That difference changes what a company needs to be ready for. Not a pilot and not a reference customer, but the operational, reporting and compliance posture of an entity that contracts with CMS directly. Those are different readiness bars, and the second takes considerably longer to reach.

Two named tracks arriving next spring constitutes a planning horizon. For a company whose category is heart failure or substance use disorder, the work required to be eligible begins well before the announcement does.

Enterprise readiness is usually discussed as a fundraising topic. In a model like this one it is the entry requirement.